Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice

Open access

Abstract

AIMS/HYPOTHESIS: Several lines of evidence suggest that incretin-based therapies suppress the development of cardiovascular disease in type 2 diabetes. We investigated the possibility that glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) can prevent the development of atherosclerosis in Apoe (-/-) mice. METHODS: Apoe (-/-) mice (17 weeks old) were administered GLP-1(7-36)amide, GLP-1(9-36)amide, GIP(1-42) or GIP(3-42) for 4 weeks. Aortic atherosclerosis, oxidised LDL-induced foam cell formation and related gene expression in exudate peritoneal macrophages were determined. RESULTS: Administration of GLP-1(7-36)amide or GIP(1-42) significantly suppressed atherosclerotic lesions and macrophage infiltration in the aortic wall, compared with vehicle controls. These effects were cancelled by co-infusion with specific antagonists for GLP-1 and GIP receptors, namely exendin(9-39) or Pro(3)(GIP). The anti-atherosclerotic effects of GLP-1(7-36)amide and GIP(1-42) were associated with significant decreases in foam cell formation and downregulation of CD36 and acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) in macrophages. GLP-1 and GIP receptors were both detected in Apoe (-/-) mouse macrophages. Ex vivo incubation of macrophages with GLP-1(7-36)amide or GIP(1-42) for 48 h significantly suppressed foam cell formation. This effect was wholly abolished in macrophages pretreated with exendin(9-39) or (Pro(3))GIP, or with an adenylate cyclase inhibitor, MDL12,330A, and was mimicked by incubation with an adenylate cyclase activator, forskolin. The inactive forms, GLP-1(9-36)amide and GIP(3-42), had no effects on atherosclerosis and macrophage foam cell formation. CONCLUSIONS/INTERPRETATION: Our study is the first to demonstrate that active forms of GLP-1 and GIP exert anti-atherogenic effects by suppressing macrophage foam cell formation via their own receptors, followed by cAMP activation. Molecular mechanisms underlying these effects are associated with the downregulation of CD36 and ACAT-1 by incretins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-011-2241-2

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Suppressive effects of GLP-1 on atherosclerotic lesion development in Apoe −/− mice. Apoe −/− mice aged 17 weeks (n = 48) were infused by osmotic mini-pumps for 4 weeks. Infusions were: vehicle (control [Cont]), GLP-1(7–36)amide, exendin(9–39) (Ex), GLP-1(7–36)amide+exendin(9–39) or GLP-1(9–36)amide. At 21 weeks of age (21 W) the 48 mice were killed, as were 15 Apoe −/− mice at 17 weeks of age (17 W) (before infusion). a–f The aortic surface was stained with oil red O. Yellow arrows show notable atherosclerotic lesions. Cross-sections of the aortic root were stained with oil red O (g−l) or anti-MOMA-2 antibody (m−r). Black arrows show notable atheromatous plaques. s The surface atherosclerotic area, (t) the ratio occupied by atherosclerotic lesions and (u) the ratio occupied by macrophage infiltration in the aortic wall were evaluated. * p < 0.05, † p < 0.005 and ‡ p < 0.0001
Fig. 1 Suppressive effects of GLP-1 on atherosclerotic lesion development in Apoe −/− mice. Apoe −/− mice aged 17 weeks (n = 48) were infused by osmotic mini-pumps for 4 weeks. Infusions were: vehicle (control [Cont]), GLP-1(7–36)amide, exendin(9–39) (Ex), GLP-1(7–36)amide+exendin(9–39) or GLP-1(9–36)amide. At 21 weeks of age (21 W) the 48 mice were killed, as were 15 Apoe −/− mice at 17 weeks of age (17 W) (before infusion). a–f The aortic surface was stained with oil red O. Yellow arrows show notable atherosclerotic lesions. Cross-sections of the aortic root were stained with oil red O (g−l) or anti-MOMA-2 antibody (m−r). Black arrows show notable atheromatous plaques. s The surface atherosclerotic area, (t) the ratio occupied by atherosclerotic lesions and (u) the ratio occupied by macrophage infiltration in the aortic wall were evaluated. * p < 0.05, † p < 0.005 and ‡ p < 0.0001CC BY-NC · PubMed Central
Fig. 2 Suppressive effects of GIP on atherosclerotic lesion development in Apoe −/− mice. Apoe −/− mice aged 17 weeks (n = 44) were infused by osmotic mini-pumps for 4 weeks. Infusions were: vehicle (control [Cont]), GIP(1–42), (Pro3)GIP, GIP(1–42)+(Pro3)GIP or GIP(3–42). At 21 weeks of age (21 W), these 44 mice were killed, as were 15 Apoe −/− mice at 17 weeks of age (17 W) (before infusion). a–f The aortic surface was stained with oil red O. Yellow arrows show remarkable atherosclerotic lesions. Cross-sections of the aortic root were stained with oil red O (g−l) or anti-MOMA-2 antibody (m−r). Black arrows show remarkable atheromatous plaques. s The surface atherosclerotic area, (t) the ratio occupied by atherosclerotic lesions and (u) the ratio occupied by macrophage infiltration in the aortic wall were evaluated. *p < 0.05, † p < 0.005 and ‡ p < 0.0001
Fig. 2 Suppressive effects of GIP on atherosclerotic lesion development in Apoe −/− mice. Apoe −/− mice aged 17 weeks (n = 44) were infused by osmotic mini-pumps for 4 weeks. Infusions were: vehicle (control [Cont]), GIP(1–42), (Pro3)GIP, GIP(1–42)+(Pro3)GIP or GIP(3–42). At 21 weeks of age (21 W), these 44 mice were killed, as were 15 Apoe −/− mice at 17 weeks of age (17 W) (before infusion). a–f The aortic surface was stained with oil red O. Yellow arrows show remarkable atherosclerotic lesions. Cross-sections of the aortic root were stained with oil red O (g−l) or anti-MOMA-2 antibody (m−r). Black arrows show remarkable atheromatous plaques. s The surface atherosclerotic area, (t) the ratio occupied by atherosclerotic lesions and (u) the ratio occupied by macrophage infiltration in the aortic wall were evaluated. *p < 0.05, † p < 0.005 and ‡ p < 0.0001CC BY-NC · PubMed Central
Fig. 3 Foam cell formation and protein abundance of CD36, ACAT-1, ABCA1, ABCG1 and SR-BI in exudate peritoneal macrophages from 43 Apoe −/− mice infused with vehicle (control), GLP-1(7–36) or GIP(1–42). a Foam cell formation was evaluated by oxidised LDL-induced cholesteryl ester accumulation in macrophages. Control 15.2 ± 3.0 nmol/mg of cell protein. b Western blotting analyses of CD36, (c) ACAT-1, (d) ABCA1, (e) ABCG1 and (f) SR-BI abundance in macrophages. Blots (b–f) show representative results for one of each molecules; bar graphs show results from densitometric analysis of immunoblotting after normalisation with β-actin. *p < 0.05, † p < 0.005 and ‡ p < 0.0001
Fig. 3 Foam cell formation and protein abundance of CD36, ACAT-1, ABCA1, ABCG1 and SR-BI in exudate peritoneal macrophages from 43 Apoe −/− mice infused with vehicle (control), GLP-1(7–36) or GIP(1–42). a Foam cell formation was evaluated by oxidised LDL-induced cholesteryl ester accumulation in macrophages. Control 15.2 ± 3.0 nmol/mg of cell protein. b Western blotting analyses of CD36, (c) ACAT-1, (d) ABCA1, (e) ABCG1 and (f) SR-BI abundance in macrophages. Blots (b–f) show representative results for one of each molecules; bar graphs show results from densitometric analysis of immunoblotting after normalisation with β-actin. *p < 0.05, † p < 0.005 and ‡ p < 0.0001CC BY-NC · PubMed Central
Fig. 4 Expression and abundance of GLP-1R and GIPR in monocytes/macrophages and arterial SMCs. a Glp1r and (b) Gipr mRNA in exudate peritoneal macrophages and tissues as labelled from non-treated Apoe −/− mice were measured by real-time RT-PCR. c Western blotting analyses of GLP-1R and (d) GIPR abundance in exudate peritoneal macrophages of non-treated Apoe −/− mice and other mouse tissues as labelled. Three independent experiments were performed. e Immunostaining of GLP-1R or GIPR in exudate peritoneal macrophages from non-treated Apoe −/− mice. Green, GLP-1R or GIPR as indicated; red, nuclei; red + green, overlay of GLP-1R or GIPR and nuclei. Scale bars 50 μm. f GLP1R and (g) GIPR mRNA levels in human coronary artery SMCs, THP1 cells and THP1-derived macrophages. h GIPR mRNA level in human monocytes and monocyte-derived macrophages were measured by real-time RT-PCR. Results were obtained from three to six independent experiments
Fig. 4 Expression and abundance of GLP-1R and GIPR in monocytes/macrophages and arterial SMCs. a Glp1r and (b) Gipr mRNA in exudate peritoneal macrophages and tissues as labelled from non-treated Apoe −/− mice were measured by real-time RT-PCR. c Western blotting analyses of GLP-1R and (d) GIPR abundance in exudate peritoneal macrophages of non-treated Apoe −/− mice and other mouse tissues as labelled. Three independent experiments were performed. e Immunostaining of GLP-1R or GIPR in exudate peritoneal macrophages from non-treated Apoe −/− mice. Green, GLP-1R or GIPR as indicated; red, nuclei; red + green, overlay of GLP-1R or GIPR and nuclei. Scale bars 50 μm. f GLP1R and (g) GIPR mRNA levels in human coronary artery SMCs, THP1 cells and THP1-derived macrophages. h GIPR mRNA level in human monocytes and monocyte-derived macrophages were measured by real-time RT-PCR. Results were obtained from three to six independent experimentsCC BY-NC · PubMed Central
Fig. 5 In vitro suppressive effects of incretins as indicate on foam cell formation in exudate peritoneal macrophages, expressed as cholesteryl ester (CE) accumulation, from non-treated Apoe −/− mice (a−g). The doses of reagents are described in the Results section. Data were obtained from three to six independent experiments. Control 4.0 ± 1.3 (a, b), 5.2 ± 2.2 (c, d), 4.9 ± 0.4 (e, f) and 13.6 ± 0.6 nmol/mg of cell protein (g). *p < 0.05, **p < 0.01. Ex, exendin; MDL12,330A, adenylate cyclase inhibitor
Fig. 5 In vitro suppressive effects of incretins as indicate on foam cell formation in exudate peritoneal macrophages, expressed as cholesteryl ester (CE) accumulation, from non-treated Apoe −/− mice (a−g). The doses of reagents are described in the Results section. Data were obtained from three to six independent experiments. Control 4.0 ± 1.3 (a, b), 5.2 ± 2.2 (c, d), 4.9 ± 0.4 (e, f) and 13.6 ± 0.6 nmol/mg of cell protein (g). *p < 0.05, **p < 0.01. Ex, exendin; MDL12,330A, adenylate cyclase inhibitorCC BY-NC · PubMed Central
Fig. 6 Expression of MCP1 (white), VCAM1 (oblique), ICAM1 (chequer) and PAI1 (black) in human aortic endothelial cells (a). b, c Human aortic SMC proliferation under treatments as labelled. Data were obtained from three to four independent experiments; *p < 0.05, **p < 0.01, † p < 0.005. d Phalloidin-TRITC/DAPI staining showing actin cytoskeleton and nuclear morphology of human aortic SMCs with or without treatments as labelled. Scale bars 50 μm. Doses of reagents used are described in the Results section. PKF275-055 (vildagliptin analogue), DPP-4 inhibitor
Fig. 6 Expression of MCP1 (white), VCAM1 (oblique), ICAM1 (chequer) and PAI1 (black) in human aortic endothelial cells (a). b, c Human aortic SMC proliferation under treatments as labelled. Data were obtained from three to four independent experiments; *p < 0.05, **p < 0.01, † p < 0.005. d Phalloidin-TRITC/DAPI staining showing actin cytoskeleton and nuclear morphology of human aortic SMCs with or without treatments as labelled. Scale bars 50 μm. Doses of reagents used are described in the Results section. PKF275-055 (vildagliptin analogue), DPP-4 inhibitorCC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 270

Metadata

Authors
Nagashima, M., Watanabe, T., Terasaki, M., Tomoyasu, M., Nohtomi, K., Kim-Kaneyama, J., Miyazaki, A., & Hirano, T.
Affiliations
  • SHOWA Medical University (JP)
  • Tokyo University of Pharmacy and Life Sciences (JP)
Corresponding author
Hirano, T.
Venue
Diabetologia
Published
2011-07-24
Volume
54
Issue
10
Pages
2649-2659
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2075567076
Cited by
259
References
25
Citations by year
2026: 22 · 2025: 15 · 2024: 16 · 2023: 14 · 2022: 19 · 2021: 22 · 2020: 11 · 2019: 20 · 2018: 17 · 2017: 14 · 2016: 18 · 2015: 22 · 2014: 12 · 2013: 23 · 2012: 13
FWCI
12.60
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Diabetologia (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • American Heart Association
  • European Foundation for the Study of Diabetes
  • Japan Society for the Promotion of Science (19-24, 22590831, 23591341)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords
incretins, glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, atherosclerosis, ApoE-deficient mice, foam cell formation, macrophages, oxidized LDL, CD36, ACAT1, GLP-1 receptor, GIP receptor, exendin-9-39, adenylate cyclase, type 2 diabetes, antiatherogenic effects
MeSH terms
Acetyl-CoA C-Acetyltransferase, Animals, Apolipoproteins E, Cell Line, Cells, Cultured, Foam Cells, Gastric Inhibitory Polypeptide, Humans, Male, Peptide Fragments, Peptides, Blotting, Western, Mice, Knockout, Microscopy, Confocal, CD36 Antigens, Atherosclerosis, Mice, Glucagon-Like Peptide 1, Incretins, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. https://app.cochat.ai/papers/10.1007/s00125-011-2241-2
The paper
Nagashima, M., Watanabe, T., Terasaki, M., Tomoyasu, M., Nohtomi, K., Kim-Kaneyama, J., Miyazaki, A., & Hirano, T. (2011). Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia. https://doi.org/10.1007/s00125-011-2241-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.